Download Tdap - Health and Community Services

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Schistosomiasis wikipedia , lookup

Brucellosis wikipedia , lookup

Poliomyelitis wikipedia , lookup

Middle East respiratory syndrome wikipedia , lookup

Cryptosporidiosis wikipedia , lookup

Neonatal infection wikipedia , lookup

Trichinosis wikipedia , lookup

Orthohantavirus wikipedia , lookup

Hepatitis B wikipedia , lookup

Onchocerciasis wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Typhoid fever wikipedia , lookup

Cysticercosis wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Leptospirosis wikipedia , lookup

Meningococcal disease wikipedia , lookup

Gastroenteritis wikipedia , lookup

Chickenpox wikipedia , lookup

Coccidioidomycosis wikipedia , lookup

Anthrax vaccine adsorbed wikipedia , lookup

Neisseria meningitidis wikipedia , lookup

Diphtheria wikipedia , lookup

Tetanus wikipedia , lookup

Whooping cough wikipedia , lookup

Transcript
PROTECTION FROM TETANUS, DIPHTHERIA (Td) and PERTUSSIS (Tdap)
ADULT PROGRAM
Tetanus and Diphtheria (Td)
Td vaccines are indicated for active immunization against tetanus and diphtheria. Td has been used for many
years. Td vaccine can be used:
 For adults not vaccinated in childhood
 Prevention of tetanus infection in wound care management
 As a booster dose for adults every 10 years
 When necessary for emergency wound care management before the 10 years have passed
Tetanus, Diphtheria and Pertussis (Tdap)
Tdap vaccines are indicated for active immunization against tetanus, diphtheria and pertussis. Adolescents
age 14 -16 years receive Tdap vaccine in school as part of the school grade 9 immunization program. Adults
are considered to be a significant source of transmission of pertussis to infants and young children. An adult
dose of Tdap should be offered ten years after adolescent booster, Td to be administered every ten years
thereafter. Tdap vaccine is also recommended for adults who have not received a previous dose of Tdap in
adulthood.
Tetanus (lockjaw)
Tetanus is caused by bacteria present in soil, dust and manure. The bacteria release a poison that could
cause severe muscle spasms all over the body. Tightening of the jaw muscles can occur which prevents the
person from opening their mouth. Sixty percent of people who get tetanus will die from it.
Diphtheria
Diphtheria is caused by bacteria that can infect the nose and throat and prevent proper breathing. It can also
cause skin or ear infections, can lead to heart failure, nerve damage, or even death. 10% of people who get
diphtheria will die from it.
Pertussis
Pertussis (whooping cough) is caused by a bacterial infection that can be spread very easily from one person
to another. It causes severe coughing that interferes with breathing. Complications of pertussis include
seizures, convulsions, pneumonia, brain damage and death. Individuals who have been immunized may still
get the disease, but in a much milder form. Pertussis is most serious in children under two years of age.
Side effects of Td and Tdap vaccines
Side effects for Td and Tdap vaccines are mild and last only a few days after the vaccine is administered and
can include:
 Mild pain, swelling and redness at the needle site are common.
 A mild fever,
 Loss of appetite
 Tiredness may occur for a day or two.
 Although rare, serious side effects or allergic reactions (e.g. anaphylaxis, hives, difficulty breathing) are
possible and may occur as with any vaccination.
Contact your family doctor or go to the nearest emergency room immediately if you experience any serious
reactions.
Who should not get Td/Tdap




Individuals who are sick with an moderate to severe acute illness with or without a fever
Individuals who are allergic to any component of the vaccine
Individuals who have had a severe reaction to this vaccine in the past
Individuals with a history of Guillain-Barre syndrome within 6 weeks of a previous tetanus vaccine dose
For additional information and
services contact your Regional
Health Authority.
DC-053A- 14
September 2014